Dear Editor,

Recent literature has associated obesity with peri-implantitis.1,2  The human metabolism is a conglomeration of complex chemical interconnections that maintain life. Among these chemicals are cytokines that regulate metabolism.

Leptin is a cytokine that influences multiple tissues, but primarily the regulation of adipose tissue. It is made by adipose cells and small intestine enterocytes. Leptin is also involved with energy regulation, hunger inhibition, and food intake.3 

Leptin is produced primarily by white adipose tissue. Leptin serum levels vary with body fat mass and time of day.4,5  Emotional stress, insulin, and dexamethasone cause increases of leptin production.6  Obstructive sleep apnea in obese patients causes an increase in leptin production but after sleep apnea treatment the production level returns to normal.7  Increases in testosterone cause a decrease in leptin and an increase of estrogen causes an increase of leptin.8 

In obesity there is a decreased leptin sensitivity, similar to that as may occur in type 2 diabetic insulin resistance. This results in a lack of satiation even though there are high levels of glycogen and leptin.9 

Leptin acts directly on a wide range of cell receptors and acts in concert with other regulatory metabolic agents.10  Leptin can augment angiogenesis and endothelial proliferation.10 

Leptin participates in bone mass regulation.11  Cancellous bone is attenuated, and cortical bone is augmented with metabolic leptin. Leptin acts in the hypothalamus and also directly to regulate bone metabolism.11 

Leptin generation is a response to fat-cell derived inflammation and increased production of leukocytes.12  It prevents metabolic stress on tissue caused by overeating and metabolic stress leads to inflammation and ectopic fat storage.13 

Leptin is found in tooth gingival crevicular fluid (GCF).14  The leptin in GCF in obese patients can be reduced after non-surgical periodontal treatment and local tetracycline treatment but the GCF leptin level returns after about 45 days post-treatment.14  Nonsurgical periodontal treatment is not effective in keeping a low level of leptin in GCF in chronic periodontitis.2 

A statistically significant positive correlation was seen between the levels of IL-1β, a major proinflammatory cytokine in peri-implant sulcular fluid and waist circumference.15 

Peri-implant sulcular fluid contains diagnostic markers that can aid in the diagnosis and monitoring of peri-implant disease. There may be key biomarkers that can be identified for this end.16  Levels of interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-10, IL-12, IL-17A, tumor necrosis factor (TNF)-α, C-reactive protein, osteoprotegerin, leptin, and adiponectin were assayed in GCF and peri-implant sulcus fluid. There were higher levels of IL-17A and TNF-α fluid in peri-implant sulcular fluid than GCF.16  There was significant correlation between probing depth around implants and levels of IL-1β and IL-8 in peri-implant sulcular fluid. Peri-implant sulcular fluid biomarkers, including leptin, may be useful in diagnosis and monitoring peri-implant health and disease.2,16 

Titanium and zirconia are both very biocompatible materials. Nonetheless, during peri-implantitis leptin is elevated and acts as a pro-inflammatory cytokine around titanium abutments.16,17  The significance of this is yet to be seen.

Leptin is found in the sulcular fluid around dental implants and may be reduced after surgical treatment for peri-implantitis.1,17  Leptin is considered to be a biomarker, but even though leptin is present, it is not an effective marker to monitor peri-implantitis progression.1,17 

We know that the patient's metabolic inflammatory reaction to disease is more important than the pathogen itself.18  The panoply of involved cytokines will need to be identified as to their importance as metabolic actors or as simply byproducts of enzymatic reactions. It remains to be seen if metabolic markers like leptin truly have active roles in peri-implantitis. The obese dental implant patient may need to have an informed consent that mentions this parameter.

1. 
Wohlfahrt
 
JC,
Aass
 
AM,
Granfeldt
 
F,
Lyngstadaas
 
SP,
Reseland
 
JE.
Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis
.
J Clin Periodontol
.
2014
;
41
:
424
431
.
2. 
Recker
 
EN,
Avila-Ortiz
 
G,
Fischer
 
CL,
et al
A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients
.
J Periodontol
.
2015
;
86
:
264
272
.
3. 
Sinha
 
MK,
Opentanova
 
I,
Ohannesian
 
JP,
et al
Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting
.
J Clin Invest
.
1996
;
98
:
1277
1282
.
4. 
Bado
 
A,
Levasseur
 
S,
Attoub
 
S,
et al
The stomach is a source of leptin
.
Nature
.
1998
;
394
:
790
793
.
5. 
Sinha
 
MK,
Ohannesian
 
JP,
Heiman
 
ML,
et al
Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects
.
J Clin Invest
.
1996
;
97
:
1344
1347
.
6. 
Otsuka
 
R,
Yatsuya
 
H,
Tamakoshi
 
K,
Matsushita
 
K,
Wada
 
K,
Toyoshima
 
H.
Psychological stress and serum leptin concentrations in Japanese men
.
Obesity (Silver Spring)
.
2006
;
14
:
1832
1838
.
7. 
Zirlik
 
S,
Hauck
 
T,
Fuchs
 
FS,
Neurath
 
MF,
Konturek
 
PC,
Harsch
 
IA.
Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome
.
Med Sci Monit.
2011
;
17:CR159–CR164.
8. 
Ahima
 
RS,
Prabakaran
 
D,
Mantzoros
 
C,
et al
Role of leptin in the neuroendocrine response to fasting
.
Nature
.
1996
;
382
:
250
252
.
9. 
Pan
 
H,
Guo
 
J,
Su
 
Z.
Advances in understanding the interrelations between leptin resistance and obesity
.
Physiol Behav
.
2014
;
130
:
157
169
.
10. 
Margetic
 
S,
Gazzola
 
C,
Pegg
 
GG,
Hill
 
RA.
Leptin: a review of its peripheral actions and interactions
.
Int J Obes Relat Metab Disord
.
2002
;
26
:
1407
1433
.
11. 
Frodermann
 
V,
Rohde
 
D,
Courties
 
G,
et al
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells
.
Nat Med
.
2019
;
25
:
1761
1771
.
12. 
Hamrick
 
MW,
Ferrari
 
SL.
Leptin and the sympathetic connection of fat to bone
.
Osteoporos Int
.
2008
;
19
:
905
912
.
13. 
Mabuchi
 
T,
Yatsuya
 
H,
Tamakoshi
 
K,
et al
Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women
.
Diabetes Metab Res Rev
.
2005
;
21
:
441
447
.
14. 
Meharwade
 
VV,
Gayathri
 
GV,
Mehta
 
DS.
Effects of scaling and root planing with or without a local drug delivery system on the gingival crevicular fluid leptin level in chronic periodontitis patients: a clinico-biochemical study
.
J Periodontal Implant Sci
.
2014
;
44
:
118
125
.
15. 
Elangovan
 
S,
Brogden
 
KA,
Dawson
 
DV,
et al
Body fat indices and biomarkers of inflammation: a cross-sectional study with implications for obesity and peri-implant oral health
.
Int J Oral Maxillofac Implants
.
2014
;
29
:
1429
1434
.
16. 
Barwacz
 
CA,
Brogden
 
KA,
Stanford
 
CM,
Dawson
 
DV,
Recker
 
EN,
Blanchette
 
D.
Comparison of pro-inflammatory cytokines and bone metabolism mediators around titanium and zirconia dental implant abutments following a minimum of 6 months of clinical function
.
Clin Oral Implants Res
.
2015
;
26
:
e35
e41
.
17. 
Brum
 
RS,
Duarte
 
PM,
Canto
 
GL,
et al
Biomarkers in biological fluids in adults with periodontitis and/or obesity: a meta-analysis
.
J Indian Soc Periodontol
.
2020
;
24
:
191
215
.
18. 
van Erp
 
K,
Dach
 
K,
Koch
 
I,
Heesemann
 
J,
Hoffmann
 
R.
Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica
.
Physiol Genomics
.
2006
;
25
:
75
84
.